Recruitment And Diversity

41. Seeing Firsthand The Transformative Impact Of AI On Pharmacovigilance And Clinical Research 11/27/2024

    Consultants Aashna Goyal and Guriqbal Singh share first-persona accounts of how AI is transforming pharmacovigilance and clinical research by improving data processing, enhancing decision-making, and accelerating drug development.

42. Patient Weighs Altruism, Self-Preservation, And Historical Mistrust In Decision To Enroll In Trial 11/22/2024

    In part three of this series on underserved patient enrollment, patient advocate Bill Allen shares why he enrolled in a clinical trial for both himself and the Black community.

43. Enrollment Mishap Emboldens Patient To Advocate For Minority Participation 11/21/2024

    In part two of this series on underserved patient enrollment, PAN Foundation patient advocate Tony Newberne shares how narrowly missed trial enrollment and how the experience inspired him to advocate for clinical research in minority communities.

44. The PAN Foundation Expands Resources For Underserved Patient Populations 11/20/2024

    In part one of this series on underserved patient enrollment, PAN Foundation CMO Amy Niles discusses the Foundation's efforts to improve access to and affordable healthcare for (including in clinical research) underserved patient populations.

45. Call To Include More Pregnant And Breastfeeding Women In Research 11/12/2024

    In this Q&A, UCB Global Head, Women of Childbearing Age Program Marie Teil reiterates the importance of including women of childbearing age, including pregnant and breastfeding women, in clinical research and explains why it’s a priority for UCB.

46. How Can "The Godfather Of Influence" Help Improve Clinical Trial Recruitment? 11/5/2024

    Patient recruitment consultant Ross Jackson taps into the principle of influence presented by business book author Robert Cialdini and illustrates how it can help improve clinical trial recruitment.

47. What Can We Learn From A Highly Diverse Observational Study Of 17,000+ Patients? 11/4/2024

    CMO William Audeh, MD, details Agendia’s diverse, high-enrolling trial and how sponsor companies of investigational trials might benefit from its experiences. 

48. PI Talks Recruitment, Retention, & Trial Design For Multiple Myeloma Studies 10/28/2024

    Multiple myeloma specialist James Berenson, MD discusses trial selection, recruitment strategies, patient-centric trial design, and more.

49. Overcoming Trial Barriers By Looking Through The Lens Of Product Adoption 10/17/2024

    In the final article of this series, Liam and Kim Eves explore how various drug candidates come inherent with barriers to adoption that directly impact how participants and providers engage with clinical research. 

50. Understanding How Strategies For Product Adoption Can Inform Clinical Trial Delivery 10/16/2024

    In part two of this series, Liam and Kim Eves discuss product archetypes and adoption drivers as they relate to commercial endeavors and looks closely at how they can be applied to clinical trial execution.